Bicara Therapeutics

BICARA THERAPEUTICS INC

Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b.

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ALVO

BBGI

BCAX

ELTX

FOXO

ISPC

JBHT

LYTS

MDXG

NATR

NUKK

OFIX

TMCI

TXNM

VIAV

WILC

Explora los mayores ganadores y perdedores en las operaciones previas al mercado. Descubre qué impulsó estos movimientos destacados.

Las acciones de Versus Systems (VS) aumentan un 71%; 20 acciones que se mueven en el premercado de EE.UU.

Bicara Therapeutics Inc

Arbutus Biopharma Corporation - Common Stock

Arbutus Biopharma

AnaptysBio

CareDx

Day One Biopharmaceuticals, Inc. - Common Stock

Day One Biopharmaceutical

Immatics

Inventiva S.A. - American Depository Shares

Inventiva

KalVista Pharmaceuticals, Inc. - Common Stock

KalVista Pharmaceuticals

Keros Therapeutics

Kura Oncology

MeiraGTx Hldgs

Myriad Genetics

Organogenesis Holdings

Oruka Therapeutics

Prime Medicine

Palvella Therapeutics, Inc. - Common Stock

Palvella Therapeutics

Rigel Pharmaceuticals, Inc. - Common Stock

Rigel Pharmaceuticals

Relay Therapeutics

Rezolute

Tango Therapeutics

Tourmaline Bio

Tyra Biosciences

Vir Biotechnology

Verastem

Xencor

Zenas BioPharma

HC Wainwright & Co.

Piper Sandler

Wells Fargo

Cantor Fitzgerald

Wedbush

Comments

Bicara Therapeutics

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL